51 related articles for article (PubMed ID: 38158099)
1. Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis.
Gong G; Ganesan K; Liu Y; Huang Y; Luo Y; Wang X; Zhang Z; Zheng Y
J Ethnopharmacol; 2024 Apr; 323():117655. PubMed ID: 38158099
[TBL] [Abstract][Full Text] [Related]
2. Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in vitro and in vivo.
Gong G; Wan Y; Liu Y; Zhang Z; Zheng Y
Int Immunopharmacol; 2024 May; 132():111959. PubMed ID: 38554442
[TBL] [Abstract][Full Text] [Related]
3. [Stellera chamaejasme against multidrug resistance of triple-negative breast cancer MDA-MB-231 cell through Nrf2].
Zeng R; Wang XX; Cui XH; Yang Q; Zhu XX; Wang YJ
Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(8):2222-2229. PubMed ID: 38812237
[TBL] [Abstract][Full Text] [Related]
4. Nano-inducer of ferroptosis for targeted chemotherapy of human triple negative breast carcinoma.
Shetake NG; Das SK; Kumar A; Pandey BN
Biomater Adv; 2024 Jul; 161():213868. PubMed ID: 38677038
[TBL] [Abstract][Full Text] [Related]
5. Peiminine triggers ferroptosis to inhibit breast cancer growth through triggering Nrf2 signaling.
Yi N; Wang L; Jiang Z; Xu G; Li L; Zhang Y; Tan Y
Tissue Cell; 2024 Apr; 87():102323. PubMed ID: 38412577
[TBL] [Abstract][Full Text] [Related]
6. Novel Withanolides from
Huang L; Wei Y; Ni M; Hu H; Xi L; Wang C; Zhu Z; Yang B; Zhao H
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675657
[TBL] [Abstract][Full Text] [Related]
7. Ursolic acid inhibits the proliferation of triple‑negative breast cancer stem‑like cells through NRF2‑mediated ferroptosis.
Yang X; Liang B; Zhang L; Zhang M; Ma M; Qing L; Yang H; Huang G; Zhao J
Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38847277
[TBL] [Abstract][Full Text] [Related]
8. SOCS1 acts as a ferroptosis driver to inhibit the progression and chemotherapy resistance of triple-negative breast cancer.
Wang Y; Pang X; Liu Y; Mu G; Wang Q
Carcinogenesis; 2023 Dec; 44(8-9):708-715. PubMed ID: 37665951
[TBL] [Abstract][Full Text] [Related]
9. Bioactive compound schaftoside from Clinacanthus nutans attenuates acute liver injury by inhibiting ferroptosis through activation the Nrf2/GPX4 pathway.
Yu Y; Liang J; Yuan Z; Wang A; Liu X; Chen Y; Zhang M; Gao Y; Zhang H; Liu Y
J Ethnopharmacol; 2024 Jun; 328():118135. PubMed ID: 38556139
[TBL] [Abstract][Full Text] [Related]
10. Targeting CAR and Nrf2 improves cyclophosphamide bioactivation while reducing doxorubicin-induced cardiotoxicity in triple-negative breast cancer treatment.
Stern S; Liang D; Li L; Kurian R; Lynch C; Sakamuru S; Heyward S; Zhang J; Kareem KA; Chun YW; Huang R; Xia M; Hong CC; Xue F; Wang H
JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35579950
[TBL] [Abstract][Full Text] [Related]
11. Danggui buxue tang suppresses high glucose-induced proliferation and extracellular matrix accumulation of mesangial cells via inhibiting lncRNA PVT1.
Zhang R; Li J; Huang T; Wang X
Am J Transl Res; 2017; 9(8):3732-3740. PubMed ID: 28861164
[TBL] [Abstract][Full Text] [Related]
12. Danggui buxue tang inhibits 2,4-dinitrochlorobenzene: induced atopic dermatitis in mice.
Fang LW; Cheng CC; Hwang TS; Huang WC; Liou CJ; Chen WC; Wu SJ
Evid Based Complement Alternat Med; 2015; 2015():672891. PubMed ID: 25861366
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis as a promising targeted therapy for triple negative breast cancer.
Mokhtarpour K; Razi S; Rezaei N
Breast Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38874688
[TBL] [Abstract][Full Text] [Related]
14. Ling-Gui-Zhu-Gan decoction protects against doxorubicin-induced myocardial injury by downregulating ferroptosis.
Yang YL; Zhao CZ; Zhao CC; Wen ZY; Ma YY; Zhao XN; Wang L; Huang JL; Zhou P
J Pharm Pharmacol; 2024 Apr; 76(4):405-415. PubMed ID: 38241142
[TBL] [Abstract][Full Text] [Related]
15. Rhein potentiates doxorubicin in treating triple negative breast cancer by inhibiting cancer-associated fibroblasts.
Xu S; Zheng S; Ma N; Zhang H; Shi J; Huang J; Luo N; Wang M; Xiong Y
Biochem Pharmacol; 2024 May; 223():116139. PubMed ID: 38499109
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Nrf2 reverses ferroptosis induced by Arenobufagin in gastric cancer.
Long J; Wang W; Chu J; Li Y; Wang M; Su J; Yang Y; Wang G; Li Q; Cheng H
Toxicol Appl Pharmacol; 2024 Mar; 484():116842. PubMed ID: 38307257
[TBL] [Abstract][Full Text] [Related]
17. G-4 inhibits triple negative breast cancer by inducing cell apoptosis and promoting LCN2-dependent ferroptosis.
Sun G; Wang J; Liu F; Zhao C; Cui S; Wang Z; Liu Z; Zhang Q; Xiang C; Zhang Y; Galons H; Yu P; Teng Y
Biochem Pharmacol; 2024 Apr; 222():116077. PubMed ID: 38395264
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol loaded extracellular vesicles sensitize triple-negative breast cancer to doxorubicin in both in-vitro and in vivo models.
Patel N; Kommineni N; Surapaneni SK; Kalvala A; Yaun X; Gebeyehu A; Arthur P; Duke LC; York SB; Bagde A; Meckes DG; Singh M
Int J Pharm; 2021 Sep; 607():120943. PubMed ID: 34324983
[TBL] [Abstract][Full Text] [Related]
19. A chemo/chemodynamic nanoparticle based on hyaluronic acid induces ferroptosis and apoptosis for triple-negative breast cancer therapy.
Wang N; Zhang Q; Wang Z; Liu Y; Yang S; Zhao X; Peng J
Carbohydr Polym; 2024 Apr; 329():121795. PubMed ID: 38286559
[TBL] [Abstract][Full Text] [Related]
20. L-lysine Increases the Anticancer Effect of Doxorubicin in Breast Cancer by Inducing ROS-Dependent Autophagy.
Jahani M; Yarani R; Rezazadeh D; Tahmasebi H; Hoseinkhani Z; Kiani S; Mansouri K
Curr Cancer Drug Targets; 2024 Apr; ():. PubMed ID: 38584530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
